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1. Introduction
Membrane fusion is involved in a wide variety of
biological processes, from sperm–oocyte fusion, to
myoblast fusion during muscle development, to a
large number of intracellular membrane trafficking
) Corresponding author. Department of Biochemistry, Apartado
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events that participate in protein synthesis and target-
ing, as well as in endo and exocytosis. However, the
best characterized fusion process relates to cell infec-
tion by lipid-enveloped viruses, namely to the merg-
ing of the viral envelope with a target cell membrane,
resulting in viral nucleocapsid delivery into the cyto-
plasm. This is due to the simplicity of the system,
where generally only one or two envelope proteins
 .present in large quantities mediate bilayer mixing.
Of all the lipid enveloped viruses that have been
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studied, influenza virus has been, by far, the major
source of information, and its sole fusogenic protein,
 .designated hemagglutinin HA , has therefore be-
come a paradigmatic model in this field of research.
Influenza virus enters target cells by receptor-
mediated endocytosis, and is delivered to an intra-
cellular acidic organelle, the endosome. The low pH
of this compartment triggers a massive conforma-
tional change in the HA, rendering it fusion-active,
and thus promoting merging between the viral enve-
w xlope and the endosomal membrane 1–3 . The entry
of influenza virus into target cells has therefore a
small time window, taking place only after arrival of
infectious particles in the endosome, and requiring
completion before the virus comes into contact with
lysosomal hydrolases. This may explain the fact that
influenza virus, as other low pH-dependent viruses,
normally fuses very quickly and effectively, when
compared with viruses that enter target cells by direct
fusion between the envelope and the cell plasma
w xmembrane at neutral pH, such as Sendai virus 4–6 .
Influenza virus HA is a homotrimeric glycoprotein
synthesized in infected cells as an inactive precursor
 .designated HA0 , and only becomes fusion-com-
petent when cleaved into two subunits, HA1 and
w xHA2, joined by disulfide bonds 7 . At neutral pH,
˚HA trimers form spikes that project "130 A from
 X.the viral envelope Fig. 1A,A , each monomer con-
 .taining a globular head region HA1 , responsible for
viral binding to target membrane sialic acid the
.biological receptor for the virus , and an envelope-
 .anchored stem region HA2 . As mentioned above,
HA-mediated membrane fusion only takes place fol-
lowing a protein conformational change at low pH,
 X. w xoccurring in at least two steps Fig. 1B,B 8 :
 .exposure of a short hydrophobic peptide "20 a.a.
localized at the N-terminal of HA2, and that was
previously buried inside the protein, and dissociation
of the globular heads i.e., each monomeric HA1
.drifts apart from the other two . The hydrophobic
w xpeptide is essential for membrane merging 9 , and
has thus been dubbed the ‘fusion peptide’. It is
generally agreed that, under acidic conditions as found
in the endosome, the HA conformational change
takes place quickly, is irreversible, and if the protein
cannot trigger fusion due to the absence of a target
.membrane, or to poor positioning of the virus , its
activity is also rapidly and irreversibly lost, a process
w xknown as viral inactivation 1,5 . However, recent
data seem to suggest that at low pH, HA may main-
tain its fusogenic ability for long periods of time, and
be therefore capable to mediate membrane mixing,
albeit to a much lesser degree, several hours after the
w xconformational change has been triggered 6 . The
possibility that at least some aspects of the conforma-
tional change, namely related to the positioning of
HA in relation to its putative target membrane at
neutral and acidic pH, may be reversible, has also
w xbeen noted 10 . Another proposal suggests that only
very few HA trimers on the envelope participate in
fusion, and actually undergo physiologically relevant
w xpH-dependent structure alterations 11 .
 .Fig. 1. A model for the mechanism of influenza virus hemagglutinin HA -mediated membrane fusion. Left: Specific binding of influenza
 .  .HA green occurs via interactions of the globular domains of HA HA1 with sialic acid residues located on either glycoproteins or
 .glycolipids of the target membrane at neutral pH blue dots, A . At low pH, the HA conformational change is triggered, resulting in
exposure of the hydrophobic HA2 N-terminal peptide and its projection towards the target membrane at the tip of the newly formed long
 .  .  .helix red , and concomitant partial opening of the trimer B . Beside the conformational change per se active HAs are drawn together,
 .clustering at a ‘fusion site’ B, C . Further separation of the HA1 ‘heads’ and the tilted positioning of the HA at low pH would result in
 .bringing the two bilayers closer together C . Initial membrane merging involves a lipidic intermediate, with mixing of the external
 .leaflets of both bilayers hemifusion, D . Ultimately, the hemifusion stage will evolve into a single monolayer contact region that later
 .  .collapses into a small fusion pore E . The further enlargement of the pore F is possibly due to the action of the fusion peptide. Note that
the peptide has now virtually reversed its initial low pH orientation. Right: In the absence of target membrane sialic acid, virus binding at
 X.neutral pH takes place unspecifically A . Therefore, when fusion is triggered at acidic pH, the HA conformational change does not
 X X.  X .necessarily result in membrane merging B , C . Under these conditions, although some HA trimers retain normal activity B , left ,
others cannot promote insertion of the fusion peptide into the target bilayer possibly due to inaccurate positioning relative to the target
X .  X .membrane, B , right , and the N-terminal peptide of HA2 may therefore ‘turn around’ and insert into the viral envelope C , right , a
process that has been linked to viral inactivation. Under these conditions, there will be a low probability for correct clustering of HAs
with the fusion peptide properly inserted in the target membrane, thus explaining the low fusion activity of influenza virus towards target
 .membranes that lack specific viral receptors. See text for further discussion .
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Although much information has already been ob-
tained, complete elucidation of the molecular mecha-
nism of membrane fusion as mediated by the in-
fluenza HA has been hindered by several constraints.
One important issue is the limited structural data
available, especially with respect to the fusion-active
 .low pH conformation of the protein see below .
Another aspect concerns the many different systems
used to probe the activity of HA, and by the concomi-
tant difficulty in bringing together data from several
experimental frameworks. These systems include ei-
ther intact virions, reconstituted HA in lipid mono or
bilayers, or cells expressing HA on their plasma
membrane fusing with a wide variety of artificial and
biological target membranes, fusion being quantified
with an array of different methods.
There are limitations to virtually all of the systems
mentioned. Thus, in vivo virions are subject to endo-
cytosis, a gradual drop in pH, following which they
fuse with the inner leaflet of a target membrane the
.endosomal bilayer , conditions never met in kinetic
studies of viral fusion activity. In addition, many
assays employing intact virions have used non-
physiological approaches virus–target membrane
prebinding in the cold at neutral pH, viral fusion
activity monitored at very low temperatures, abrupt
.pH adjustments during fusion in an effort to slow
down the process, and to rend it more amenable to
analysis. Several stages in HA-mediated fusion have
been characterized in this manner, although their
exact physiological relevance is open to discussion.
On the other hand, while the use of cells expressing
HA is paramount in obtaining certain data such as in
.patch clamp studies of fusion pore formation , it is
obvious that they do not accurately represent the
normal organization of the fusogenic protein in the
intact virus, both in terms of protein density, associa-
tion with other viral proteins, not to mention the
existence on the plasma membrane of many other
 .cellular proteins. Finally, it should also be noted
that HAs from different viral strains may have slightly
w xdistinctive properties 11–14 . This being said, and
although the precise nature and characteristics of a
given system under study is obviously important,
influenza HA will most likely mediate fusion always
in the same basic manner, irrespective of experimen-
tal conditions and viral strains. Any model proposed
to explain its action must, thus, be a global model,
including data from all sources available, and ac-
counting for the behavior of the fusogenic protein as
a whole. Based on the recent publication of new and
challenging observations, such a model is presented
 .and discussed below Fig. 1 . The relevance of mem-
brane fusion mediated by the HA in terms of extrapo-
lating results obtained with this model protein to
other biological membrane merging events will also
be briefly evaluated.
2. A working model for influenza hemagglutinin
fusion activity
2.1. First contact: role of target membrane ˝iral
receptors in membrane merging
The first step in HA-mediated membrane fusion
consists of binding between the viral envelope and a
target membrane at neutral pH. Binding occurs via
the HA1 globular subunits, which specifically recog-
nize sialic acid residues on the target bilayer Fig.
. w x1A 1,7 , but can also take place unspecifically, i.e.,
 X. w xvia non-sialic acid containing sites Fig. 1A 15 .
Specific binding is seldomly discussed in terms of the
low pH-dependent fusion activity of influenza virus.
However, it has been shown that target membrane
sialic acid can directly modulate HA-mediated mem-
w xbrane merging 15 , strongly suggesting that specific
viral attachment is crucial for correct HA organiza-
w xtion at the fusion site 15,16 . Other suggestions
imply that bound HAs do not directly mediate the
fusion process, but instead help create the correct
environment and membrane proximity for the bilayer
merging action of non-bound trimers, possibly by
w x allowing their clustering at the fusion site 17,18 see
.below .
2.2. Turning it on: low pH conformational changes in
the HA structure
Following viral binding and endocytosis, the HA
undergoes the low pH-induced conformational
change, which, as mentioned earlier, involves both
exposure of the hydrophobic N-terminal fusion pep-
tide from HA2, and dissociation of the trimer globu-
 X.lar HA1 subunits trimer opening; Fig. 1B,B . The
importance of these two phenomena have been widely
discussed. Thus, while fusion peptide exposure was
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considered essential for membrane merging, trimer
opening was dubbed irrelevant, and only involved in
w xlow-pH viral inactivation 19,20 . However, two lines
of evidence seem to contradict this possibility. On
one hand, inhibition of globular head dissociation by
.linking trimer HA1 subunits via disulfide bonds was
shown to greatly impair fusion, due to a lack of
w xfusion peptide exposure 21,22 . On the other hand,
kinetic analysis strongly suggested that both low
pH-dependent fusion activity and inactivation shared
a common molecular mechanism, and thus relied on
w xsimilar structural changes in the HA 5 .
2.3. Disturbing influences: insertion of the ˝iral fu-
sion peptide into the target membrane bilayer
The key role of the hydrophobic fusion peptide
located at the N-terminal of HA2 in HA-mediated
membrane merging has long been thought to involve
an interaction with the target membrane that would
induce destabilization at the contact zone. Indeed,
several studies have shown that the peptide can pene-
trate target membranes prior to fusion, strongly sug-
gesting that this might be the first step in membrane
 . w xmixing per se Fig. 1B 11,23,24 , although it should
be mentioned that fusion peptide insertion alone may
not lead to membrane mixing, and that these pre-fu-
sion interactions are much less evident when biologi-
w xcal membranes are used as targets for the virus 14 .
One major difficulty in rationalizing fusion peptide
insertion into the target bilayer was the fact that the
peptide is located at the base of the HA at neutral pH
 X.Fig. 1A,A . However, predictions with synthetic
w xpeptides 25 and partial solving of the low pH
w xstructure of HA 26 , have shown that drastic rear-
rangements take place, including major transitions in
several regions of the molecule from loop to helical
and vice versa. This results in the formation of a long
w xhelix that can project upward 25,26 . Since the fu-
sion peptide is located at the tip of the low pH-gener-
ated helix, it can thus be propelled into the target
 .membrane Fig. 1B . Peptide insertion, possibly in an
w xoblique position 27,28 , may also be made easier by
the fact that fusion-active HA assumes a tilted posi-
 . w xtion in the viral envelope at low pH Fig. 1B,C 29 .
As discussed earlier, lack of a target membrane,
inadequate positioning of the virus on the target
membrane surface, or absence of HA binding to
specific receptors result in viral inactivation at low
pH. It has been proposed that this process results
from insertion of the fusion peptide into the viral
envelope, after the low pH-formed long HA2 helix
w xchanges direction 30,31 . Therefore, in the absence
of a target membrane that could modulate specific
HA binding, insertion of the fusion peptide into
bilayers would take place in an random fashion Fig.
X X. w x1B ,C 15,16 . In the presence of the target bilayer,
the two postulated movements of the fusion peptide
projection towards the target, followed by reversal of
.orientation back to the envelope might be the main
w xdriving force in membrane merging 3,26,32 . These
movements could be made possible by a change from
helix to loop in a region of the HA stem that could
 .thus function as a ‘hinge’ Fig. 1C–F .
It should be stressed that structural data are avail-
able for only a soluble fragment of HA2 at low pH
w x26 , and still lacking is concrete knowledge of the
way the fusogenic protein is placed in the viral
envelope during fusion, and, more importantly, the
exact structure of the fusion peptide when interacting
with a target membrane. Using synthetic peptides
corresponding to the N-termini of several HAs both
a-helixes and b-strands were detected, with a slight
w xpredominance of the former structure 28 . Moreover,
it was also shown that lower fusion activity corre-
lated with an increase in b-strands, suggesting that
the peptide, which assumes a random conformation in
aqueous solution, may form a helix when in contact
w xwith the target membrane 28 . Such a mechanism
has been proposed to actually assist in bringing to-
w xgether the fusing membranes 33 .
2.4. Key cooperations: participation of se˝eral HA
trimers at the fusion site
Various lines of indirect evidence have implied
that several HA trimers had to be involved in each
fusion site therefore suggesting the concerted action
.of several fusion peptides , and a lag phase, of vary-
ing duration, between acidification and membrane
merging has therefore been interpreted as the re-
quired time for low pH association of trimers Fig.
. w x1B,C 17,34,35 . Recent calculations based on ki-
netic analysis have yielded a minimal number of
w x w xthree 36 and six 37 trimers per fusion event. It
should also be mentioned that alterations in fusion
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peptide interaction with target bilayers during the lag
phase andror in the very early stages of the fusion
itself, possibly as the result of trimer organization at
w xthe contact site, have been proposed 11,14 . In the
absence of specific HA binding, trimer organization,
as well as fusion peptide penetration into membranes,
would occur at random, thus explaining the low
fusion activity of influenza virus towards membranes
w xlacking sialic acid receptors 6,15 .
2.5. A question of bulk: o˝ercoming physical barriers
to final contact between membranes
Once HA higher order complexes are formed, the
process of membrane merging per se can take place.
However, a major hurdle to be overcome concerns
the presence at the fusion site of several very bulky
glycoproteins, that can act as steric barriers to mem-
brane contact, an issue overlooked in most models
because the HA is only partially represented typi-
cally only the low pH fragment of known structure,
.attached to a transmembrane anchor, is depicted .
There are two processes that may contribute to solve
this problem. On one hand, the tilted position of HA
w xhas already been mentioned 29 . On the other hand,
trimer head dissociation could again be important in
removing the globular HA1 subunits from the fusion
 . site Fig. 1B,C,D . If the globular heads remain as
.postulated in the model attached to target membrane
receptors, opening of the trimers could directly pro-
mote close contact between the apposing membranes.
In this respect, it should be noted that even low
pH-inactivated virions retain most of their binding
w xability, at neutral and acidic pH 5 . Both processes
mentioned above could explain the establishment of
direct contact between the viral envelope and the
endosome membrane.
2.6. In˝ol˝ement of proteins and lipids: early inter-
mediates in the coalescence of aqueous compart-
ments
Although HA-induced fusion is protein-mediated,
it had already been suggested that the membrane
fusion event itself would take place in target mem-
w xbrane protein-free areas 17 . The use of mutant
GPI-anchored HAs has shown that lack of a protein
transmembrane domain induced hemifusion i.e.,
mixing of only the outer monolayers of fusing mem-
.branes , therefore implying that a lipidic intermediate
w xstate was involved 38 . However, it was also possi-
ble that these observations resulted from the lack of
the transmembrane region, and were not physio-
logically relevant.
Another favored model for the architecture of the
fusion site postulated that initial contact between
aqueous compartments would take place via a pro-
w xtein-lined ‘fusion pore’ 37,39,40 , akin to what has
been modeled in the case of fusion during exocytosis
w x41 . These models arose mainly from the observation
that aqueous contact between compartments could be
established before exchange of lipids between the
two membranes, a possible problem in the interpreta-
tion of the data being that pore opening assays were
more sensitive than the equivalent lipid-mixing tech-
niques. This would help explain the fact that lipids
have been recently shown to be paramount in mem-
brane merging, and especially that they can modulate
the bilayer mixing process before the establishment
of any aqueous contact between compartments de-
w xfined by fusing membranes can be detected 42 . The
observation that hemifusion induced by GPI-anchored
HA can lead to complete fusion in the presence of
modulators of membrane curvature seems to point in
w xthe same direction 43 . Thus, it seems likely that the
initial contact between aqueous compartments will be
mediated by lipids possibly forming a highly curved
.hourglass-like ‘stalk’ intermediate , whose behavior
has been directly or indirectly conditioned by the HA,
 .namely by its fusion peptide Fig. 1D . Following the
formation of a hemifusion structure, this will likely
w xevolve into a single monolayer contact region 43
 .that later collapses into a small fusion pore Fig. 1E .
Interestingly, the fusion peptide has also been impli-
w xcated in pore widening 44 , suggesting that its pres-
ence in the fusion site might be important in the final
 .consummation of membrane fusion Fig. 1E,F .
3. Perspectives
In the model for HA-mediated membrane fusion
presented above, we have integrated information ob-
tained from many studies, on a wide variety of
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experimental systems, in an effort to produce a de-
tailed account of the process at the molecular level.
Accordingly, we have taken into consideration all
aspects of HA function, including those often over-
looked by other authors for reasons of simplicity,
such as the modulating role of target membrane sialic
acid on fusion activity, and the role of globular head
dissociation in the merging of bilayers. The picture is
however not complete, and will likely be revised as
more information on the precise structure of HA at
the fusion site is unveiled, especially since low pH
conformation structure is only known for fragments
of the protein. This pictorial hypothesis could be
useful in bringing together structural considerations
and evidence obtained from kinetic studies.
As far as other biological fusion reactions are
concerned, it is possible that HA mediated fusion
could serve as a broader paradigm. However, any
extrapolations should be made with caution, as it is
becoming clear that, although most viral fusion pro-
teins share many distinctive characteristics, the way
they perform their respective membrane merging
w xevents may be quite different 1,2,45 .
Nevertheless, the sperm integral membrane protein
fertilin has been described as a likely candidate for
the fusion factor responsible for membrane merging
during fertilization, since it has been shown to pos-
sess several of the characteristics common to many
viral fusion proteins. These characteristics include
synthesis as an inactive precursor, existence of tightly
linked subunits, and possibility of formation of high-
order oligomers, as well as existence of a putative
fusion peptide in the a subunit of the protein for
w x.recent reviews see Refs. 45,46 , although recent
observations suggest that the human a fertilin might
w xbe non-functional 47 , and that fusion during fertil-
w xization could involve other proteins 48 .
But if events such as fertilization or myoblast
fusion could be considered similar to cell infection by
lipid-enveloped viruses, since both involve fusion of
structures facing an extracellular medium, it is un-
clear whether the same type of rationalism could be
imported to intracellular membrane fusion. For exam-
ple, regulation of intracellular fusion events involved
in membrane trafficking might be accomplished solely
by elaborate mechanisms regarding fusion inhibition
of naturally unstable membranes, until proper dock-
ingrpriming can be achieved, thus precluding the
need for specific fusion proteins. Nevertheless, the
study of these intracellular events has been hindered,
not only by the complexity of the system, which
makes it difficult to isolate and properly reconsti-
.tute any given fusion event for kinetic analysis, but
also by the lack of precise structural data on the
many proteins involved. However, it has been pro-
posed that the synaptic vesicle membrane protein
synaptobrevin may mediate membrane fusion during
the exocytotic release of neurotransmitters in all
likelihood, the best characterized intracellular fusion
.event , possibly via a fusion peptide akin to those
wfound in viral proteins for a recent review, see Ref.
w xx49 . Although more information is still needed,
preliminary results suggest that synaptobrevin could
indeed be directly involved in membrane mixing at
w xthe synapse 50 .
Also of importance are the recent findings con-
cerning the active participation of lipids in HA-medi-
ated membrane fusion. Such findings are remarkable
in that lipids have usually been considered secondary
players in a protein-regulated process, their presence
only being rationalized in terms of the maintenance
 .of stable platforms membranes andror compart-
ments suitable for protein function. However, recent
studies have demonstrated that several biological
membrane fusion events including exocytosis and
.viral fusion can be directly influenced by membrane
w xlipids 42,43,51 . Concomitantly, it is becoming in-
creasingly clear that intracellular membrane traffick-
ing may also involve changes in lipid bilayers that
could facilitate vesicle budding andror fusion. In this
respect, activation of phospholipase D during intra-
cellular signaling, with subsequent production of
 .phosphatidic acid a well known fusogenic lipid , is
the best example of possible lipid participation in
w xmembrane destabilization during trafficking 52 . It is
also likely that this previously not sufficiently appre-
ciated area of research will yield many new develop-
ments in years to come.
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